Neudle.com: atypical parkinsonism

Differential
(Click to cross reference)

advances in neurology

adverse drug reaction

anticholinergic drugs

anticholinergic drugs, side effects of

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eyelid opening

autoimmune cerebellar ataxia

autoimmune disease

autonomic cardiovascular reflexes

autonomic dysfunction

basal ganglia, infarction

basal ganglia, lesion, bilateral

burst suppression pattern, electroencephalogram

CAT scan, emission, abnormal

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebrovascular accident

cerebrovascular disease

chromosome 19

cingulate island sign

Clinical Pathologic Conference(C.P.C.)

cortical-basal ganglionic degeneration

cycling

degenerative diseases of CNS

dementia, frontotemporal

dementia, subcortical

differential diagnosis

drug induced neurologic disorders

drug interactions

dyskinesia

dyskinesia, drug induced

dysphagia

dystonia

dystonia, drug induced

dystonia, face

dystonia, focal

dystonic reaction, acute

efficacy

electroconvulsive therapy

electron microscopy

emergencies, neurologic

emergency room

encephalitis, autoimmune

enzyme inhibition

epidemiology of neurology

erectile dysfunction

ergotamine

evidence-based research

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

falling

familial

fever

fine motor function, impaired

fluoxetine

frontal behavioral spatial syndrome

gait disorder

gait, apraxic

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, supranuclear

gaze palsy, vertical

gene mutation

gene therapy

genetic neurologic disorders

genetic testing

glutamic acid decarboxylase, antibody

heralding manifestation

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

iatrogenic neurologic disorders

inclusion bodies, eosinophilic cytoplasmic

intracranial hypotension

jealousy

L-dopa

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

leg spasms, painful

leucine rich glioma inactivated 1 antibodies

leukemia, neurologic findings assoc.with

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

memory, impairment of

meningitis

microangiopathy, brain

midbrain

midbrain, atrophy

mimics

Mini Mental Status Examination

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

multiple sclerosis, treatment of

multiple system atrophy

neurofilament light chain protein

neurofilaments

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic disease, diagnoses of

neurologic disease, tempo

neuropathology, brain

nortriptyline

obsessive-compulsive disorder

olanzapine

old age, neurology of

ondansetron

ophthalmoplegia

ophthalmoplegia, total

orthostatic hypotension

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, benign tremulous

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, heterogeneity of

Parkinson disease, intractable

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism hyperpyrexia syndrome

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

patient information and support

penguin silhouette sign

personality change

phenothiazine

phenothiazine, dyskinesia associated with

postural abnormality

practice guidelines

preclinical

primary intracranial hypotension

prognosis

progressive neurologic disorder

progressive supranuclear palsy

pseudobulbar palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

psychosis

psychotic behavior

pull test

pyramidal tract dysfunction

quetiapine

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading disorder, acquired

reading problem, causes of

Red flags

remote effect of cancer on the nervous system

saccadic eye movements

saccadic eye movements, abnormal

safety

sagging of the brain

salivation, excessive

seizure

selective serotonin reuptake inhibitors

sequencing difficulty

serotonin syndrome

shoulder, pain in

sinemet

single photon emission computed tomography

skin, biopsy

sleep pathology and physiology

stimulation, deep brain

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamotomy

trazodone

treatment of neurologic disorder

tremor

tremor, intention

tremor, resting

tremor, surgical treatment of

tremor, treatment of

tricyclic antidepressant

urinary incontinence

vision, blurred

visual symptoms

walking, difficulty with

weight loss

wheelchair

wide based gait

Showing articles 600 to 650 of 1482 << Previous Next >>

Stereotactic Pallidotomy in the Treatment of Parkinson Disease,An Expert Opinion
Arch Neurol 56:1064-1069, Bronstein,J.M.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Progress in Functional Neurosurgery for Parkinson's Disease
Lancet 354:1658-1659,1665, Quinn,N., 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999

Unilateral Pallidotomy for Parkinson's Disease:Results after More Than 1 Year
JNNP 67:511-517, Schrag,A.,et al, 1999

Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999

Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Prevalence of Progressive Supranuclear Palsy and Multiple System Atrophy:A Cross-Sectional Study
Lancet 354:1771-1775, Schrag,A.,et al, 1999

Evaluation of Surgery for Parkinson's Disease, A Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 53:1910-1921, Hallett,M.,et al, 1999

Acute and Reversible Parkinsonism Due to Organophosphate Pesticide Intoxication, Five Cases
Neurol 52:1467-1471, Bhatt,M.H.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

Chronic Subthalamic Nucleus Stimulation Reduces Medication Requirements in Parkinson's Disease
Neurol 53:85-90, Moro,E.,et al, 1999

Transderm-induced Psychosis in Parkinson's Disease
Neurol 53:433-434, Minagar,A.,et al, 1999

Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999

Stereotactic Radiosurgical Pallidotomy and Thalamotomy with the Gamma Knife:MR Imaging Findings with Clinical Correlation-Preliminary Experience
Radiology 212:143-150, Friedman,D.P.,et al, 1999

A 3-Year Randomized Trial of Ropinirole and Bromocriptine in Early Parkinson's Disease
Neurol 53:364-370, Korczyn,A.D.,et al, 1999

Zolpidem in Progressive Supranuclear Palsy
NEJM 341:543-544, Daniele,A.,et al, 1999

Comparative Effects of Unilateral and Bilateral Subthalamic Nucleus Deep Brain Stimulation
Neurol 53:561-566, Kumar,R.,et al, 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Multicentre European Study of Thalamic Stimulation in Paarkinsonisn and Essential Tremor
JNNP 66:289-296, Limousin,P.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Susceptibility to Neuroleptic Malignant Syndrome in Parkinson's Disease
Neurol 52:777-781, Ueda,M.,et al, 1999

Parkinsonism after Taking Ecstasy
NEJM 340:1443, Mintzer,S.,et al, 1999

Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 340:1476-1480,1500, Bejjani,B-P.,et al, 1999

Clinicopath Conf:Multisystem Neurodegenerative Disease with Dementia Pugilistica
NEJM 340:1269-1277, Case 12-1999, 1999

The Effect of Estrogen Replacement on Early Parkinson's Disease
Neurol 52:1417-1421, Sanders-Pullman,R.,et al, 1999

Atypical Form of Amyotrophic Lateral Sclerosis
JNNP 66:581-585, Sasaki,S.&Iwata,M., 1999

Prevalence and Clinical Correlates of Psychotic Symptoms in parkinson Disease
Arch Neurol 56:595-601, Aarsland,D.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Long-Term Follow-Up of Levodopa Responsiveness in Generalized Dystonia
Arch Neurol 55:1320-1323, Dewey,R.B.,et al, 1998

The Risk of Parkinson's Disease with Exposure to Pesticides, Farming, Well Water, and Rural Living
Neurol 50:1346-1350, Gorell,J.M.,et al, 1998

Mortality in People Taking Selegiline:Observational Study
BMJ 317:252-254, Thorogood,M.,et al, 1998

A 6-Year-Old Child with Vacant Episodes and Unilateral Convulsions
Lancet 352:1750, Burgner,D.,et al, 1998

Olfactory Dysfunction in Guamanian ALS,Parkinsonism,and Dementia
Neurol 51:1672-1677, Ahlskog,J.E.,et al, 1998

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998

Unilateral Thalamic Deep Brain Stimulation for Refractory Essential Tremor and Parkinson's Disease Tremor
Neurol 51:1063-1069, Ondo,W.,et al, 1998

Bilateral High-Frequency Stimulation of the Internal Globus Pallidus in Advanced Parkinson's Disease
Ann Neurol 44:953-961, Volkmann,J.,et al, 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Functional Neurosurgery for parkinson's Disease, Has Come a Long Way, Though Much Remains Experimental
BMJ 316:1259-1260, Quinn,N.&Bhatia,K., 1998

Pallidotomy for Parkinson's Disease:Hitting the Target
Lancet 351:998-999, Golbe,L.I., 1998

Neuropsychological Consequences of Posteroventral Pallidotomy for the Treatment of Parkinson's Disease
Neurol 51:207-215, Trepanier,L.L.,et al, 1998

Cognitive Functioning After Pallidotomy for Refractory Parkinson's Disease
JNNP 65:150-154, 1481998., Perrine,K.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Clinical Usefulness of Magnetic Resonance Imaging in Multiple System Atrophy
JNNP 65:65-71, Schrag,A.,et al, 1998

Double-Blind Evaluation of Subthalamic Nucleus Deep Brain Stimulation in Advanced Parkinson's Disease
Neurol 51:850-855, Kumar,R.,et al, 1998

Effect of Selegiline on Mortality in Patients with Parkinson's Disease
Neurol 51:825-830, Olanow,C.W.,et al, 1998

Showing articles 600 to 650 of 1482 << Previous Next >>